-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CvNODcFjIxEAwDDMJAi/tQXIkfqW2HMUUrQvoc9CPW7k51VG6BkTiylY5aJwdyHr 70sNgdm4t+CtZc37v6MQMw== /in/edgar/work/20000621/0000891836-00-000459/0000891836-00-000459.txt : 20000920 0000891836-00-000459.hdr.sgml : 20000920 ACCESSION NUMBER: 0000891836-00-000459 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000621 GROUP MEMBERS: PHARMACIA & UPJOHN AB GROUP MEMBERS: PHARMACIA & UPJOHN HOLDINGS B.V. GROUP MEMBERS: PHARMACIA & UPJOHN, INC. GROUP MEMBERS: PHARMACIA CORP /DE/ SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: INSITE VISION INC CENTRAL INDEX KEY: 0000802724 STANDARD INDUSTRIAL CLASSIFICATION: [2834 ] IRS NUMBER: 943015807 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-42661 FILM NUMBER: 658622 BUSINESS ADDRESS: STREET 1: 445 MARINE VIEW AVE STREET 2: SUITE 100 CITY: DEL MAR STATE: CA ZIP: 92014 BUSINESS PHONE: 5108658800 MAIL ADDRESS: STREET 1: 445 MARINE VIEW AVE STREET 2: SUITE 100 CITY: DEL MAR STATE: CA ZIP: 92014 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACIA CORP /DE/ CENTRAL INDEX KEY: 0000067686 STANDARD INDUSTRIAL CLASSIFICATION: [2800 ] IRS NUMBER: 430420020 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 100 ROUTE 206 NORTH CITY: PEAPACK STATE: NJ ZIP: 07977 BUSINESS PHONE: 888-768-5501 MAIL ADDRESS: STREET 1: 100 ROUTE 206 NORTH CITY: PEAPACK STATE: NJ ZIP: 07977 FORMER COMPANY: FORMER CONFORMED NAME: MONSANTO CO DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: MONSANTO CHEMICAL CO DATE OF NAME CHANGE: 19711003 SC 13G/A 1 0001.txt SCHEDULE 13G, AMENDMENT NO. 2 ------------------------------ OMB APPROVAL ------------------------------ OMB Number: 3235-0145 Expires: October 31, 2002 Estimated average burden hours per response 14.90 ------------------------------ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* InSite Vision Incorporated - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, Par Value $0.01 Per Share - -------------------------------------------------------------------------------- (Title of Class of Securities) 457660 10 8 ------------------------------- (CUSIP Number) January 18, 2000 -------------------------------- Date of Event Which Requires Filing of this Statement Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [x] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). POTENTIAL PERSONS WHO ARE TO RESPOND TO THE COLLECTION OF INFORMATION CONTAINED IN THIS FORM ARE NOT REQUIRED TO RESPOND UNLESS THE FORM DISPLAYS A CURRENTLY VALID OMB CONTROL NUMBER. SCHEDULE 13G/A - ------------------------- ------------------------- CUSIP No. 457660 10 8 Page 2 of 7 Pages - ------------------------- ------------------------- - ------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS. I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY). Pharmacia & Upjohn AB - ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (A) [ ] (B) [ ] - ------------------------------------------------------------------------------- 3 SEC USE ONLY - ------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Sweden - ------------------------------------------------------------------------------- NUMBER OF 5 SOLE VOTING POWER SHARES BENEFICIALLY 2,665,614 OWNED BY ------------------------------------------------------- EACH 6 SHARED VOTING POWER REPORTING PERSON -0- WITH ------------------------------------------------------- 7 SOLE DISPOSITIVE POWER 2,665,614 ------------------------------------------------------- 8 SHARED DISPOSITIVE POWER -0- - ------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,665,614 - ------------------------------------------------------------------------------- 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - ------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 10.8% - ------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO - ------------------------------------------------------------------------------- SCHEDULE 13G/A - ------------------------- ------------------------- CUSIP No. 457660 10 8 Page 3 of 7 Pages - ------------------------- ------------------------- - ------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS. I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY). Pharmacia & Upjohn Holdings B.V. - ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (A) [ ] (B) [ ] - ------------------------------------------------------------------------------- 3 SEC USE ONLY - ------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Netherlands - ------------------------------------------------------------------------------- NUMBER OF 5 SOLE VOTING POWER SHARES BENEFICIALLY 2,665,614 OWNED BY ------------------------------------------------------- EACH 6 SHARED VOTING POWER REPORTING PERSON -0- WITH ------------------------------------------------------- 7 SOLE DISPOSITIVE POWER 2,665,614 ------------------------------------------------------- 8 SHARED DISPOSITIVE POWER -0- - ------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,665,614 - ------------------------------------------------------------------------------- 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - ------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 10.8% - ------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO - ------------------------------------------------------------------------------- SCHEDULE 13G/A - ------------------------- ------------------------- CUSIP No. 457660 10 8 Page 4 of 7 Pages - ------------------------- ------------------------- - ------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS. I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY). Pharmacia & Upjohn, Inc. - ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (A) [ ] (B) [ ] - ------------------------------------------------------------------------------- 3 SEC USE ONLY - ------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - ------------------------------------------------------------------------------- NUMBER OF 5 SOLE VOTING POWER SHARES BENEFICIALLY 2,665,614 OWNED BY ------------------------------------------------------- EACH 6 SHARED VOTING POWER REPORTING PERSON -0- WITH ------------------------------------------------------- 7 SOLE DISPOSITIVE POWER 2,665,614 ------------------------------------------------------- 8 SHARED DISPOSITIVE POWER -0- - ------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,665,614 - ------------------------------------------------------------------------------- 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - ------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 10.8% - ------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO - ------------------------------------------------------------------------------- SCHEDULE 13G/A - ------------------------- ------------------------- CUSIP No. 457660 10 8 Page 5 of 7 Pages - ------------------------- ------------------------- - ------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS. I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY). Pharmacia Corporation - ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (A) [ ] (B) [ ] - ------------------------------------------------------------------------------- 3 SEC USE ONLY - ------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - ------------------------------------------------------------------------------- NUMBER OF 5 SOLE VOTING POWER SHARES BENEFICIALLY 2,665,614 OWNED BY ------------------------------------------------------- EACH 6 SHARED VOTING POWER REPORTING PERSON -0- WITH ------------------------------------------------------- 7 SOLE DISPOSITIVE POWER 2,665,614 ------------------------------------------------------- 8 SHARED DISPOSITIVE POWER -0- - ------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,665,614 - ------------------------------------------------------------------------------- 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] [ ] - ------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 10.8% - ------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO, HC - ------------------------------------------------------------------------------- CUSIP Number: 457660 10 8 Page 6 of 7 Pharmacia & Upjohn AB (formerly Pharmacia AB), a Swedish corporation ("P&U AB"), Pharmacia & Upjohn Holdings BV, a "check the box" entity incorporated in the Netherlands ("P&U BV") and Pharmacia & Upjohn, Inc. ("P&U Inc."), and Pharmacia Corporation (formerly Monsanto Company), a Delaware corporation ("PHA", and together with the P&U AB, P&U BV and P&U Inc. the "Reporting Persons") hereby amend the report on Schedule 13G/A (the "Schedule 13G/A") filed by the Reporting Persons on April 10, 2000, with respect to shares of Common Stock, par value $0.01 per share (the "Shares"), of Insite Vision Incorporated, a Delaware corporation ("Insite"), beneficially owned by them. Capitalized terms used but not defined herein shall have the meaning attributed to such terms in the Schedule 13G/A. ITEM 4. OWNERSHIP. Item 4 of the Schedule 13G/A is amended in its entirety as follows: (a). P&U AB beneficially owns 2,665,614 Shares of InSite. P&U BV, P&U Inc. and PHA may be each deemed to beneficially own 2,665,614 Shares of InSite. (b). The percentage interest held by each Reporting Person presented below is based on the number of Shares reported to be outstanding as of May 30, 2000 in Insite's Registration Statement on Form S-3, filed June 1, 2000 (the "Outstanding Shares"). P&U AB beneficially owns approximately 10.8% of the Outstanding Shares. P&U BV, P&U Inc. and PHA may be each deemed to beneficially own approximately 10.8% of the Outstanding Shares. (c). Each Reporting Person has the power to vote or direct the vote and dispose or direct the disposition of the Shares beneficially owned by such Reporting Persons as indicated in pages 2 through 5 above. CUSIP Number: 457660 10 8 Page 7 of 7 ITEM 10. CERTIFICATION. By signing below we certify that, to the best of our knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: June 21, 2000 PHARMACIA CORPORATION By: /s/ Don W. Schmitz ---------------------------- Name: Don W. Schmitz Title: Corporate Secretary INDEX TO EXHIBITS Exhibit No. Exhibit - ----------- ------- 99.1 Joint Filing Statement, dated April 10, 2000, between Pharmacia & Upjohn AB, Pharmacia & Upjohn Holdings BV, Pharmacia & Upjohn, Inc. and Pharmacia Corporation (incorporated herein by reference to Schedule 13G/A filed on April 10, 2000) 99.2 Item 7 Information (incorporated herein by reference to Schedule 13G/A filed on April 10, 2000) -----END PRIVACY-ENHANCED MESSAGE-----